Illumina is trying to reduce the uncertainty surrounding its leadership and direction by naming a new CEO.
Jacob Thaysen, the current and president of Agilent Technologies’ life sciences and applied markets group, will take over as Illumina's chief executive officer, starting on 25 September. Thaysen...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?